HTA210 The Use of Surrogate Endpoints in Health Technology Assessments (HTAs) for Chronic Cancers

Abstract

Authors

R Campden J Yu C Tzonev M Musat D Thakur

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×